HOLUBIAK MYRON Z — SEC insider filings

SEC reporting owner CIK 1199080. 17 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-10-09 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Citius Pharmaceuticals, Inc. (CTXR)Vice Chairman, Director9——19
CITIUS ONCOLOGY, INC. (CTOR)Secretary, Director7——10
ASSEMBLY BIOSCIENCES, INC. (ASMB)Director1——1

Insider filings — HOLUBIAK MYRON Z

FiledFormIssuerReported transactionsSource
2026-11-124CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-12-224/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 850,000 @ $0EDGAR
2025-12-014/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 850,000 @ $0EDGAR
2025-09-234CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 850,000 @ $0 · Grant/award (A): 100,000 @ $0EDGAR
2025-08-124Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 31,373 (derivative) · Grant/award (A): 31,373 (derivative) · Disposition to issuer (D): 22,344 (derivative) · Grant/award (A): 22,344 (derivative)EDGAR
2024-12-164CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-11-124Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 350,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2024-09-274Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 784,314 (derivative) · Grant/award (A): 784,314 (derivative) · Disposition to issuer (D): 558,597 (derivative) · Grant/award (A): 558,597 (derivative)EDGAR
2024-08-304/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,500,000 (derivative) @ $0EDGAR
2024-08-144CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2024-04-054Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 129,450 (derivative) · Grant/award (A): 129,450 (derivative)EDGAR
2023-10-124Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2022-10-064Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2021-10-134Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 650,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-264Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-05-244ASSEMBLY BIOSCIENCES, INC. (ASMB)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2020-10-094Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1199080 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs